Filing Flows › cbdMD (YCBD) › Q4 FY25
cbdMD (YCBD) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Dec 19, 2025
cbdMD (YCBD) reported revenue of $4.7M for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +2% from the quarter before. Operating margin was -14.5%, net loss $680K (14.4% of revenue).
cbdMD, Q4 FY25: revenue $4.7M (+4% year over year), operating margin -14.5%, net loss $680K, operating cash flow −$241K. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7M | +2% | +4% |
| Operating profit | −$686K | — | — |
| Net earnings | −$680K | — | — |
| Operating cash flow | −$241K | — | -244% |
What changed
Revenue was $4.7M in Q4 FY25, up 4% year over year and up 2% from the previous quarter.
Gross margin was 58.8%, up 5.0 points from Q4 FY24. Operating costs exceeded revenue by $686K, an operating margin of -14.5%. Operating expenses grew 25% against revenue growth of 4%. The quarter ended with a net loss of $680K, narrower than the previous quarter's $895K loss.
Operating cash flow was −$241K. Non-cash charges added back $262K of depreciation and amortization. Working capital and other items added $177K. Capital expenditures of $3K exceeded it, leaving free cash flow of −$244K.
Questions
What was cbdMD's revenue in the fourth quarter fiscal 2025?
cbdMD (YCBD) reported revenue of $4.7M for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +2% from the quarter before.
Was cbdMD profitable in the fourth quarter fiscal 2025?
Operating loss was $686K (-14.5% of revenue) and net loss $680K.
Source: cbdMD 10-K on SEC EDGAR.